Moreover, like in breast, endometrial and ovarian cancer, ERα protein is increased, ERβ protein is decreased and finally the ERα/ERβ protein ratio is upregulated, which is involved in the occurrence and development of PTC21–24. The gene discussed is ESR1; the disease is ovarian carcinoma.